Summaries for Patients |

Screening for Dementia in Primary Care Settings FREE

[+] Article, Author, and Disclosure Information

The summary below is from the full reports titled “Screening for Dementia: Recommendation and Rationale” and “Screening for Dementia in Primary Care: A Summary of the Evidence for the U.S. Preventive Services Task Force.” They are in the 3 June 2003 issue of Annals of Internal Medicine (volume 138, pages 925-926 and pages 927-937). The first report was written by the U.S. Preventive Services Task Force; the second report was written by M. Boustani, B. Peterson, L. Hanson, R. Harris, and K.N. Lohr.

Ann Intern Med. 2003;138(11):I-60. doi:10.7326/0003-4819-138-11-200306030-00006
Text Size: A A A

What is the U.S. Preventive Services Task Force?

The U.S. Preventive Services Task Force (USPSTF) is a group of health experts that reviews published research and makes recommendations about preventive health care.

What is the problem and what is known about it so far?

Dementia is a condition that affects memory and thinking enough to interfere with normal daily activities. About 1 out of every 10 Americans older than 65 years of age has some degree of dementia. Poor memory alone is not dementia, and some declines in short-term memory are normal as people age. Several diseases can cause dementia, but the two most common are Alzheimer disease and cerebrovascular dementia. In Alzheimer disease, the buildup of abnormal proteins damages brain cells. In cerebrovascular dementia, low blood flow to the brain damages brain cells. There is no cure for dementia. However, drugs called cholinesterase inhibitors can modestly slow the worsening of disease. Also, some nondrug management strategies might be useful in delaying the need for nursing home care. Doctors should consider a diagnosis of dementia if a patient reports problems with memory and thinking. However, it is unclear whether it makes sense for primary care doctors to screen for dementia in patients who do not report these problems. Screening is looking for a specific condition in people who do not report symptoms of that condition.

How did the USPSTF develop these recommendations?

The USPSTF reviewed published research to evaluate the benefits and harms of screening primary care patients for dementia. For screening to make sense, several circumstances need to exist. First, the condition must be common. Second, there must be a good way to test for the condition. Third, treatment must be available. Fourth, patients treated early (before symptoms develop) must do better than patients treated later (after symptoms develop). Fifth, the potential harms of screening must not outweigh the benefits.

What did the USPSTF find?

The USPSTF authors found that no studies evaluated the benefits and harms of screening for dementia. They did find studies suggesting that brief examinations can detect dementia. However, only about half of the people who have positive results on brief examinations actually have dementia confirmed by more rigorous tests. Studies show that treatment with cholinesterase inhibitors for 6 to 12 months can modestly slow the worsening of dementia but only minimally affects patient function. There is very limited information about other types of treatments for dementia. No good studies have addressed other potential benefits and harms of screening for this disorder.

What does the USPSTF suggest that patients do?

The USPSTF recommends neither for nor against screening for dementia in primary care patients who do not have symptoms of memory loss or confusion. If patients or their relatives notice memory problems, they should tell their doctors because testing for dementia might be reasonable in this situation.

What are the cautions related to these recommendations?

As better studies become available, the USPSTF may modify these recommendations.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.